Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study

ObjectivesThe current study aimed to examine the association between the number of medications, polypharmacy, and frailty in community-dwelling older adults. In addition, the cutoff score for the number of medications related with frailty in this sample was determined.MethodsA cross-sectional analys...

Full description

Bibliographic Details
Main Author: Bader Alqahtani
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1148671/full
_version_ 1797820360096219136
author Bader Alqahtani
author_facet Bader Alqahtani
author_sort Bader Alqahtani
collection DOAJ
description ObjectivesThe current study aimed to examine the association between the number of medications, polypharmacy, and frailty in community-dwelling older adults. In addition, the cutoff score for the number of medications related with frailty in this sample was determined.MethodsA cross-sectional analysis was performed using data of 328 individual aged between 65 and 85 years from the Midlife in the United States (MIDUS 2): Biomarker Project, 2004–2009, a multisite longitudinal study, for 328 individuals aged between 65 and 85 years. All the participants were categorized into two groups based on the number of medications used: no polypharmacy (n = 206) and polypharmacy (n = 122). The polypharmacy was defined as having 5 or more medication per day. Frailty status was measured using a modified form of Fried frailty phenotype through the presences of the following indicators include low physical activity; exhaustion; weight loss; slow gait speed and muscle weakness. Participants were categorized into three different groups based on total score: 0 as robust, 1 to 2 as prefrail, 3 or more as frail. The relationship between no. of medications, polypharmacy, and frailty was examined using a multinomial logistic regression model. The model was adjusted for age, sex, BMI, and no. of chronic conditions. Receiver operator characteristics and area under the curve were used to determine the cutoff number of medications.ResultsNumber of medications, and polypharmacy were associated with being frail (relative risk ratio [RRR]: 1.30; 95% confidence interval [CI]: [1.12, 1.50], p = 0.001), (RRR: 4.77; 95% CI [1.69, 13.4], p = 0.003), respectively. Number of medications with cutoff 6 medication or more was associated with being in frail category with sensitivity of 62% and specificity of 73%.ConclusionPolypharmacy was shown to be significantly related to frailty. A cutoff score of 6 or more medications distinguished frail from non-frail. Addressing polypharmacy in the older population might ameliorate the impact of physical frailty.
first_indexed 2024-03-13T09:37:14Z
format Article
id doaj.art-41033ea5b9d14168828db1b308f559f1
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-13T09:37:14Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-41033ea5b9d14168828db1b308f559f12023-05-25T10:04:16ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-05-011110.3389/fpubh.2023.11486711148671Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States studyBader AlqahtaniObjectivesThe current study aimed to examine the association between the number of medications, polypharmacy, and frailty in community-dwelling older adults. In addition, the cutoff score for the number of medications related with frailty in this sample was determined.MethodsA cross-sectional analysis was performed using data of 328 individual aged between 65 and 85 years from the Midlife in the United States (MIDUS 2): Biomarker Project, 2004–2009, a multisite longitudinal study, for 328 individuals aged between 65 and 85 years. All the participants were categorized into two groups based on the number of medications used: no polypharmacy (n = 206) and polypharmacy (n = 122). The polypharmacy was defined as having 5 or more medication per day. Frailty status was measured using a modified form of Fried frailty phenotype through the presences of the following indicators include low physical activity; exhaustion; weight loss; slow gait speed and muscle weakness. Participants were categorized into three different groups based on total score: 0 as robust, 1 to 2 as prefrail, 3 or more as frail. The relationship between no. of medications, polypharmacy, and frailty was examined using a multinomial logistic regression model. The model was adjusted for age, sex, BMI, and no. of chronic conditions. Receiver operator characteristics and area under the curve were used to determine the cutoff number of medications.ResultsNumber of medications, and polypharmacy were associated with being frail (relative risk ratio [RRR]: 1.30; 95% confidence interval [CI]: [1.12, 1.50], p = 0.001), (RRR: 4.77; 95% CI [1.69, 13.4], p = 0.003), respectively. Number of medications with cutoff 6 medication or more was associated with being in frail category with sensitivity of 62% and specificity of 73%.ConclusionPolypharmacy was shown to be significantly related to frailty. A cutoff score of 6 or more medications distinguished frail from non-frail. Addressing polypharmacy in the older population might ameliorate the impact of physical frailty.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1148671/fullfrailtyagingolderpolypharmacymedications
spellingShingle Bader Alqahtani
Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
Frontiers in Public Health
frailty
aging
older
polypharmacy
medications
title Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
title_full Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
title_fullStr Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
title_full_unstemmed Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
title_short Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study
title_sort number of medications and polypharmacy are associated with frailty in older adults results from the midlife in the united states study
topic frailty
aging
older
polypharmacy
medications
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1148671/full
work_keys_str_mv AT baderalqahtani numberofmedicationsandpolypharmacyareassociatedwithfrailtyinolderadultsresultsfromthemidlifeintheunitedstatesstudy